Capital Analysts, LLC Bio Rad Laboratories, Inc. Transaction History

Capital Analysts, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$334.87 - $493.06 $46,546 - $68,535	-139 Closed	0 $0
Q1 2020 May 08, 2020	SELL	$320.01 - $409.07 $13,120 - $16,771	-41 Reduced 22.78%	139 $49,000
Q2 2019 Aug 13, 2019	SELL	$286.93 - $312.59 $6,312 - $6,876	-22 Reduced 10.89%	180 $56,000
Q1 2019 May 13, 2019	SELL	$224.3 - $317.41 $7,401 - $10,474	-33 Reduced 14.04%	202 $61,000
Q3 2018 Nov 07, 2018	SELL	$289.28 - $326.15 $33,556 - $37,833	-116 Reduced 33.05%	235 $0
Q2 2018 Aug 03, 2018	SELL	$244.1 - $303.88 $9,031 - $11,243	-37 Reduced 9.54%	351 $0
Q1 2018 May 14, 2018	SELL	$233.97 - $274.11 $14,272 - $16,720	-61 Reduced 13.59%	388 $97,000
Q4 2017 Feb 14, 2018	SELL	$216.94 - $271.3 $5.17 Million - $6.47 Million	-23,831 Reduced 98.15%	449 $107,000
Q4 2017 Feb 12, 2018	BUY	$216.94 - $271.3 $5.12 Million - $6.4 Million	23,578 Added 3358.69%	24,280 $4.11 Million
Q3 2017 Nov 06, 2017	BUY	$212.27 - $242.28 $149,013 - $170,080	702	702 $156,000

457

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.46B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Capital Analysts, LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Analysts, LLC with notifications on news.